Beate Klimm

1.9k total citations
32 papers, 1.1k citations indexed

About

Beate Klimm is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Beate Klimm has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Neurology. Recurrent topics in Beate Klimm's work include Lymphoma Diagnosis and Treatment (30 papers), Lung Cancer Treatments and Mutations (14 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Beate Klimm is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Lung Cancer Treatments and Mutations (14 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Beate Klimm collaborates with scholars based in Germany, United States and Switzerland. Beate Klimm's co-authors include Andreas Engert, Volker Diehl, Peter Borchmann, Michael Fuchs, Karolin Behringer, Bastian von Tresckow, Thorsten Reineke, Hans Theodor Eich, Michael May and L. Wildt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The FASEB Journal.

In The Last Decade

Beate Klimm

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beate Klimm Germany 17 781 473 339 284 236 32 1.1k
Silvia Franceschetti Italy 17 751 1.0× 366 0.8× 245 0.7× 161 0.6× 139 0.6× 47 1.3k
Martin Soekler Germany 12 395 0.5× 273 0.6× 156 0.5× 181 0.6× 124 0.5× 23 616
C. Cirrincione United States 14 291 0.4× 653 1.4× 303 0.9× 285 1.0× 81 0.3× 23 1.4k
Corinne Brillant Germany 16 701 0.9× 567 1.2× 306 0.9× 331 1.2× 73 0.3× 32 1.1k
Jennifer L. Kelly United States 17 639 0.8× 434 0.9× 115 0.3× 59 0.2× 61 0.3× 40 1.0k
Richard R. Blough United States 15 233 0.3× 284 0.6× 87 0.3× 272 1.0× 234 1.0× 40 1.5k
Brandelyn N. Pitcher United States 19 587 0.8× 810 1.7× 107 0.3× 219 0.8× 41 0.2× 37 1.3k
Richard van der Jagt Canada 13 804 1.0× 646 1.4× 128 0.4× 84 0.3× 86 0.4× 30 1.2k
Isabella Capodanno Italy 10 374 0.5× 203 0.4× 127 0.4× 164 0.6× 35 0.1× 22 611
Michel Blanc France 14 757 1.0× 386 0.8× 427 1.3× 127 0.4× 122 0.5× 35 1.0k

Countries citing papers authored by Beate Klimm

Since Specialization
Citations

This map shows the geographic impact of Beate Klimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Klimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Klimm more than expected).

Fields of papers citing papers by Beate Klimm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Klimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Klimm. The network helps show where Beate Klimm may publish in the future.

Co-authorship network of co-authors of Beate Klimm

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Klimm. A scholar is included among the top collaborators of Beate Klimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Klimm. Beate Klimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eich, Hans Theodor, Heinz Schmidberger, Boris Böll, et al.. (2013). The German evidence-based guidelines for Hodgkin’s lymphoma. Strahlentherapie und Onkologie. 189(6). 445–447. 3 indexed citations
2.
Hay, Annette E., Beate Klimm, Bingshu E. Chen, et al.. (2013). An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Annals of Oncology. 24(12). 3065–3069. 27 indexed citations
3.
Klimm, Beate, Helen Goergen, Michael Fuchs, et al.. (2013). Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitions. Annals of Oncology. 24(12). 3070–3076. 48 indexed citations
4.
Schorb, Elisabeth, Benjamin Kasenda, J. Atta, et al.. (2013). Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica. 98(5). 765–770. 65 indexed citations
5.
Böll, Boris, Helen Goergen, Julia Meißner, et al.. (2013). Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group. Journal of Clinical Oncology. 31(35). 4431–4437. 35 indexed citations
6.
Sasse, Stephanie, Beate Klimm, Helen Görgen, et al.. (2012). Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma. Annals of Oncology. 23(11). 2953–2959. 25 indexed citations
7.
Klimm, Beate, Corinne Brillant, Nicole Skoetz, et al.. (2012). The Effect of Specialized Cancer Treatment Centers on Treatment Efficacy in Hodgkin’s Lymphoma. Deutsches Ärzteblatt international. 109(51-52). 893–9. 7 indexed citations
8.
9.
Tresckow, Bastian von, Annette Plütschow, Michael Fuchs, et al.. (2012). Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial. Journal of Clinical Oncology. 30(9). 907–913. 173 indexed citations
10.
Eichenauer, Dennis A., Michael Fuchs, Annette Pluetschow, et al.. (2011). Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood. 118(16). 4363–4365. 77 indexed citations
11.
Klimm, Beate & Andreas Engert. (2009). Combined Modality Treatment of Hodgkin’s Lymphoma. The Cancer Journal. 15(2). 143–149. 13 indexed citations
12.
Klimm, Beate & Andreas Engert. (2008). Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies. Nature Clinical Practice Oncology. 5(6). 316–323. 7 indexed citations
13.
Jetter, Alexander, Stephan Rietbrock, Dirk Kasel, et al.. (2007). Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin???s Lymphoma and its Effect on Myelotoxicity. Clinical Pharmacokinetics. 46(4). 319–333. 16 indexed citations
14.
Klimm, Beate, Andreas Engert, & Volker Diehl. (2006). First-line treatment of Hodgkin’s lymphoma. Current Hematologic Malignancy Reports. 1(1). 51–59. 16 indexed citations
15.
16.
Klimm, Beate, Andreas Engert, Corinne Brillant, et al.. (2005). Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin’s lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG. Journal of Clinical Oncology. 23(16_suppl). 6507–6507. 14 indexed citations
17.
Klimm, Beate, Roland Schnell, Volker Diehl, & Andreas Engert. (2005). Current treatment and immunotherapy of Hodgkin's lymphoma.. PubMed. 90(12). 1680–92. 27 indexed citations
18.
Klimm, Beate, Volker Diehl, Beate Pfistner, & Andreas Engert. (2005). Current treatment strategies of the German Hodgkin Study Group (GHSG). European Journal Of Haematology. 75(s66). 125–134. 15 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Franceschetti Breakdown of academic impact, for papers by Martin Soekler Breakdown of academic impact, for papers by C. Cirrincione Breakdown of academic impact, for papers by Corinne Brillant Breakdown of academic impact, for papers by Jennifer L. Kelly Breakdown of academic impact, for papers by Richard R. Blough Breakdown of academic impact, for papers by Brandelyn N. Pitcher Breakdown of academic impact, for papers by Richard van der Jagt Breakdown of academic impact, for papers by Isabella Capodanno Breakdown of academic impact, for papers by Michel Blanc
Rankless by CCL
2026